nodes	percent_of_prediction	percent_of_DWPC	metapath
Bosutinib—P-Glycoprotein Inhibitors—Cyclosporine—systemic lupus erythematosus	0.394	1	CiPCiCtD
Bosutinib—CSK—systemic lupus erythematosus	0.125	0.443	CbGaD
Bosutinib—PTK2B—Leflunomide—systemic lupus erythematosus	0.103	0.788	CbGbCtD
Bosutinib—LYN—systemic lupus erythematosus	0.0999	0.354	CbGaD
Bosutinib—BLK—systemic lupus erythematosus	0.0574	0.203	CbGaD
Bosutinib—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.00286	0.022	CbGbCtD
Bosutinib—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.00217	0.0167	CbGbCtD
Bosutinib—ABCB1—Betamethasone—systemic lupus erythematosus	0.00186	0.0143	CbGbCtD
Bosutinib—ABCB1—Prednisolone—systemic lupus erythematosus	0.00184	0.0141	CbGbCtD
Bosutinib—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.00174	0.0134	CbGbCtD
Bosutinib—ABCB1—Prednisone—systemic lupus erythematosus	0.00174	0.0133	CbGbCtD
Bosutinib—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.00172	0.0132	CbGbCtD
Bosutinib—ABCB1—Cyclosporine—systemic lupus erythematosus	0.00164	0.0126	CbGbCtD
Bosutinib—CYP3A4—Dapsone—systemic lupus erythematosus	0.0015	0.0115	CbGbCtD
Bosutinib—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0013	0.00998	CbGbCtD
Bosutinib—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0013	0.00998	CbGbCtD
Bosutinib—CYP3A4—Betamethasone—systemic lupus erythematosus	0.00112	0.00856	CbGbCtD
Bosutinib—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0011	0.00845	CbGbCtD
Bosutinib—ABCB1—Dexamethasone—systemic lupus erythematosus	0.00108	0.00831	CbGbCtD
Bosutinib—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.00104	0.00801	CbGbCtD
Bosutinib—CYP3A4—Prednisone—systemic lupus erythematosus	0.00104	0.00798	CbGbCtD
Bosutinib—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.000986	0.00756	CbGbCtD
Bosutinib—ABCB1—Methotrexate—systemic lupus erythematosus	0.00087	0.00668	CbGbCtD
Bosutinib—Vandetanib—LYN—systemic lupus erythematosus	0.000752	0.335	CrCbGaD
Bosutinib—Vandetanib—LTK—systemic lupus erythematosus	0.000713	0.317	CrCbGaD
Bosutinib—TLK1—Mycophenolic acid—Mycophenolate mofetil—systemic lupus erythematosus	0.000692	0.384	CbGdCrCtD
Bosutinib—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.000649	0.00498	CbGbCtD
Bosutinib—Vandetanib—BLK—systemic lupus erythematosus	0.000432	0.192	CrCbGaD
Bosutinib—STK25—Mycophenolic acid—Mycophenolate mofetil—systemic lupus erythematosus	0.000287	0.159	CbGdCrCtD
Bosutinib—CASK—Mycophenolic acid—Mycophenolate mofetil—systemic lupus erythematosus	0.000256	0.142	CbGdCrCtD
Bosutinib—Vandetanib—VEGFA—systemic lupus erythematosus	0.00023	0.102	CrCbGaD
Bosutinib—CSK—Mycophenolic acid—Mycophenolate mofetil—systemic lupus erythematosus	0.000152	0.0844	CbGdCrCtD
Bosutinib—FER—central nervous system—systemic lupus erythematosus	7.99e-05	0.00142	CbGeAlD
Bosutinib—TYRO3—central nervous system—systemic lupus erythematosus	7.99e-05	0.00142	CbGeAlD
Bosutinib—ALK—central nervous system—systemic lupus erythematosus	7.99e-05	0.00142	CbGeAlD
Bosutinib—ERBB3—lymphoid tissue—systemic lupus erythematosus	7.99e-05	0.00142	CbGeAlD
Bosutinib—TNK2—nervous system—systemic lupus erythematosus	7.97e-05	0.00142	CbGeAlD
Bosutinib—MAP2K2—lymphoid tissue—systemic lupus erythematosus	7.97e-05	0.00142	CbGeAlD
Bosutinib—STK36—lung—systemic lupus erythematosus	7.97e-05	0.00142	CbGeAlD
Bosutinib—EPHB3—lung—systemic lupus erythematosus	7.97e-05	0.00142	CbGeAlD
Bosutinib—LYN—central nervous system—systemic lupus erythematosus	7.95e-05	0.00142	CbGeAlD
Bosutinib—CAMK2G—bone marrow—systemic lupus erythematosus	7.93e-05	0.00141	CbGeAlD
Bosutinib—BMP2K—bone marrow—systemic lupus erythematosus	7.93e-05	0.00141	CbGeAlD
Bosutinib—MAP3K2—lymphoid tissue—systemic lupus erythematosus	7.91e-05	0.00141	CbGeAlD
Bosutinib—PTK2B—tendon—systemic lupus erythematosus	7.91e-05	0.00141	CbGeAlD
Bosutinib—MERTK—lung—systemic lupus erythematosus	7.88e-05	0.0014	CbGeAlD
Bosutinib—LRRK2—bone marrow—systemic lupus erythematosus	7.86e-05	0.0014	CbGeAlD
Bosutinib—FYN—cortex of kidney—systemic lupus erythematosus	7.83e-05	0.00139	CbGeAlD
Bosutinib—MAP3K19—central nervous system—systemic lupus erythematosus	7.83e-05	0.00139	CbGeAlD
Bosutinib—CSNK1E—tendon—systemic lupus erythematosus	7.78e-05	0.00139	CbGeAlD
Bosutinib—ERBB4—nervous system—systemic lupus erythematosus	7.76e-05	0.00138	CbGeAlD
Bosutinib—TBK1—lymphoid tissue—systemic lupus erythematosus	7.75e-05	0.00138	CbGeAlD
Bosutinib—PTK2—lymphoid tissue—systemic lupus erythematosus	7.75e-05	0.00138	CbGeAlD
Bosutinib—MAP4K4—lung—systemic lupus erythematosus	7.73e-05	0.00138	CbGeAlD
Bosutinib—TNK2—central nervous system—systemic lupus erythematosus	7.68e-05	0.00137	CbGeAlD
Bosutinib—NUAK2—lung—systemic lupus erythematosus	7.67e-05	0.00137	CbGeAlD
Bosutinib—BCR—lung—systemic lupus erythematosus	7.67e-05	0.00137	CbGeAlD
Bosutinib—PTK2B—bone marrow—systemic lupus erythematosus	7.66e-05	0.00136	CbGeAlD
Bosutinib—SIK1—tendon—systemic lupus erythematosus	7.66e-05	0.00136	CbGeAlD
Bosutinib—IRAK4—tendon—systemic lupus erythematosus	7.66e-05	0.00136	CbGeAlD
Bosutinib—ROCK1—nervous system—systemic lupus erythematosus	7.66e-05	0.00136	CbGeAlD
Bosutinib—MAP4K5—cortex of kidney—systemic lupus erythematosus	7.65e-05	0.00136	CbGeAlD
Bosutinib—MAP3K3—cortex of kidney—systemic lupus erythematosus	7.65e-05	0.00136	CbGeAlD
Bosutinib—MAP3K12—lung—systemic lupus erythematosus	7.62e-05	0.00136	CbGeAlD
Bosutinib—EPHA4—tendon—systemic lupus erythematosus	7.58e-05	0.00135	CbGeAlD
Bosutinib—ULK3—tendon—systemic lupus erythematosus	7.49e-05	0.00133	CbGeAlD
Bosutinib—MAP2K2—tendon—systemic lupus erythematosus	7.49e-05	0.00133	CbGeAlD
Bosutinib—ERBB4—central nervous system—systemic lupus erythematosus	7.47e-05	0.00133	CbGeAlD
Bosutinib—MAP2K1—lung—systemic lupus erythematosus	7.47e-05	0.00133	CbGeAlD
Bosutinib—STK35—lung—systemic lupus erythematosus	7.47e-05	0.00133	CbGeAlD
Bosutinib—RPS6KB1—lymphoid tissue—systemic lupus erythematosus	7.45e-05	0.00133	CbGeAlD
Bosutinib—BMPR2—nervous system—systemic lupus erythematosus	7.44e-05	0.00132	CbGeAlD
Bosutinib—SIK1—bone marrow—systemic lupus erythematosus	7.42e-05	0.00132	CbGeAlD
Bosutinib—IRAK4—bone marrow—systemic lupus erythematosus	7.42e-05	0.00132	CbGeAlD
Bosutinib—CSK—lung—systemic lupus erythematosus	7.42e-05	0.00132	CbGeAlD
Bosutinib—FGR—lymphoid tissue—systemic lupus erythematosus	7.41e-05	0.00132	CbGeAlD
Bosutinib—SRC—skin of body—systemic lupus erythematosus	7.4e-05	0.00132	CbGeAlD
Bosutinib—EPHB3—nervous system—systemic lupus erythematosus	7.38e-05	0.00131	CbGeAlD
Bosutinib—STK36—nervous system—systemic lupus erythematosus	7.38e-05	0.00131	CbGeAlD
Bosutinib—AXL—lymphoid tissue—systemic lupus erythematosus	7.38e-05	0.00131	CbGeAlD
Bosutinib—ROCK1—central nervous system—systemic lupus erythematosus	7.37e-05	0.00131	CbGeAlD
Bosutinib—CSNK1A1—lung—systemic lupus erythematosus	7.37e-05	0.00131	CbGeAlD
Bosutinib—MAP3K7—tendon—systemic lupus erythematosus	7.37e-05	0.00131	CbGeAlD
Bosutinib—CSF1R—connective tissue—systemic lupus erythematosus	7.36e-05	0.00131	CbGeAlD
Bosutinib—HCK—lung—systemic lupus erythematosus	7.32e-05	0.0013	CbGeAlD
Bosutinib—CLK1—lung—systemic lupus erythematosus	7.32e-05	0.0013	CbGeAlD
Bosutinib—MERTK—nervous system—systemic lupus erythematosus	7.29e-05	0.0013	CbGeAlD
Bosutinib—TBK1—tendon—systemic lupus erythematosus	7.28e-05	0.0013	CbGeAlD
Bosutinib—PTK2—tendon—systemic lupus erythematosus	7.28e-05	0.0013	CbGeAlD
Bosutinib—ABL2—lung—systemic lupus erythematosus	7.28e-05	0.0013	CbGeAlD
Bosutinib—YES1—kidney—systemic lupus erythematosus	7.26e-05	0.00129	CbGeAlD
Bosutinib—ULK3—bone marrow—systemic lupus erythematosus	7.25e-05	0.00129	CbGeAlD
Bosutinib—MAP2K2—bone marrow—systemic lupus erythematosus	7.25e-05	0.00129	CbGeAlD
Bosutinib—MAP3K2—bone marrow—systemic lupus erythematosus	7.2e-05	0.00128	CbGeAlD
Bosutinib—STK10—kidney—systemic lupus erythematosus	7.19e-05	0.00128	CbGeAlD
Bosutinib—CAMK2G—lung—systemic lupus erythematosus	7.19e-05	0.00128	CbGeAlD
Bosutinib—BMP2K—lung—systemic lupus erythematosus	7.19e-05	0.00128	CbGeAlD
Bosutinib—TAOK3—kidney—systemic lupus erythematosus	7.16e-05	0.00127	CbGeAlD
Bosutinib—BMPR2—central nervous system—systemic lupus erythematosus	7.16e-05	0.00127	CbGeAlD
Bosutinib—MAP4K4—nervous system—systemic lupus erythematosus	7.16e-05	0.00127	CbGeAlD
Bosutinib—IRAK1—tendon—systemic lupus erythematosus	7.14e-05	0.00127	CbGeAlD
Bosutinib—MAP3K7—bone marrow—systemic lupus erythematosus	7.14e-05	0.00127	CbGeAlD
Bosutinib—LRRK2—lung—systemic lupus erythematosus	7.12e-05	0.00127	CbGeAlD
Bosutinib—BCR—nervous system—systemic lupus erythematosus	7.11e-05	0.00127	CbGeAlD
Bosutinib—EPHB3—central nervous system—systemic lupus erythematosus	7.1e-05	0.00126	CbGeAlD
Bosutinib—STK36—central nervous system—systemic lupus erythematosus	7.1e-05	0.00126	CbGeAlD
Bosutinib—EGFR—lung—systemic lupus erythematosus	7.1e-05	0.00126	CbGeAlD
Bosutinib—YES1—cortex of kidney—systemic lupus erythematosus	7.07e-05	0.00126	CbGeAlD
Bosutinib—MAP3K12—nervous system—systemic lupus erythematosus	7.06e-05	0.00126	CbGeAlD
Bosutinib—TBK1—bone marrow—systemic lupus erythematosus	7.05e-05	0.00126	CbGeAlD
Bosutinib—MERTK—central nervous system—systemic lupus erythematosus	7.02e-05	0.00125	CbGeAlD
Bosutinib—RPS6KB1—tendon—systemic lupus erythematosus	7.01e-05	0.00125	CbGeAlD
Bosutinib—SRC—kidney—systemic lupus erythematosus	6.98e-05	0.00124	CbGeAlD
Bosutinib—TAOK3—cortex of kidney—systemic lupus erythematosus	6.98e-05	0.00124	CbGeAlD
Bosutinib—FGR—tendon—systemic lupus erythematosus	6.96e-05	0.00124	CbGeAlD
Bosutinib—PTK2B—lung—systemic lupus erythematosus	6.94e-05	0.00124	CbGeAlD
Bosutinib—AXL—tendon—systemic lupus erythematosus	6.94e-05	0.00123	CbGeAlD
Bosutinib—EPHA2—lymphoid tissue—systemic lupus erythematosus	6.92e-05	0.00123	CbGeAlD
Bosutinib—IRAK1—bone marrow—systemic lupus erythematosus	6.92e-05	0.00123	CbGeAlD
Bosutinib—MAP2K1—nervous system—systemic lupus erythematosus	6.91e-05	0.00123	CbGeAlD
Bosutinib—STK35—nervous system—systemic lupus erythematosus	6.91e-05	0.00123	CbGeAlD
Bosutinib—FYN—lymphoid tissue—systemic lupus erythematosus	6.9e-05	0.00123	CbGeAlD
Bosutinib—MAP4K4—central nervous system—systemic lupus erythematosus	6.89e-05	0.00123	CbGeAlD
Bosutinib—CSK—nervous system—systemic lupus erythematosus	6.87e-05	0.00122	CbGeAlD
Bosutinib—BCR—central nervous system—systemic lupus erythematosus	6.84e-05	0.00122	CbGeAlD
Bosutinib—CSNK1E—lung—systemic lupus erythematosus	6.83e-05	0.00122	CbGeAlD
Bosutinib—CSNK1A1—nervous system—systemic lupus erythematosus	6.82e-05	0.00121	CbGeAlD
Bosutinib—MAP3K12—central nervous system—systemic lupus erythematosus	6.79e-05	0.00121	CbGeAlD
Bosutinib—RPS6KB1—bone marrow—systemic lupus erythematosus	6.79e-05	0.00121	CbGeAlD
Bosutinib—HCK—nervous system—systemic lupus erythematosus	6.78e-05	0.00121	CbGeAlD
Bosutinib—CLK1—nervous system—systemic lupus erythematosus	6.78e-05	0.00121	CbGeAlD
Bosutinib—MAP4K5—lymphoid tissue—systemic lupus erythematosus	6.75e-05	0.0012	CbGeAlD
Bosutinib—FGR—bone marrow—systemic lupus erythematosus	6.74e-05	0.0012	CbGeAlD
Bosutinib—LCK—bone marrow—systemic lupus erythematosus	6.74e-05	0.0012	CbGeAlD
Bosutinib—SIK1—lung—systemic lupus erythematosus	6.72e-05	0.0012	CbGeAlD
Bosutinib—IRAK4—lung—systemic lupus erythematosus	6.72e-05	0.0012	CbGeAlD
Bosutinib—SLK—tendon—systemic lupus erythematosus	6.68e-05	0.00119	CbGeAlD
Bosutinib—MAP2K1—central nervous system—systemic lupus erythematosus	6.66e-05	0.00118	CbGeAlD
Bosutinib—STK35—central nervous system—systemic lupus erythematosus	6.66e-05	0.00118	CbGeAlD
Bosutinib—BMP2K—nervous system—systemic lupus erythematosus	6.65e-05	0.00118	CbGeAlD
Bosutinib—CAMK2G—nervous system—systemic lupus erythematosus	6.65e-05	0.00118	CbGeAlD
Bosutinib—EPHA4—lung—systemic lupus erythematosus	6.65e-05	0.00118	CbGeAlD
Bosutinib—CSF1R—skin of body—systemic lupus erythematosus	6.65e-05	0.00118	CbGeAlD
Bosutinib—EPHB4—tendon—systemic lupus erythematosus	6.63e-05	0.00118	CbGeAlD
Bosutinib—CSK—central nervous system—systemic lupus erythematosus	6.61e-05	0.00118	CbGeAlD
Bosutinib—LRRK2—nervous system—systemic lupus erythematosus	6.6e-05	0.00117	CbGeAlD
Bosutinib—ERBB3—lung—systemic lupus erythematosus	6.59e-05	0.00117	CbGeAlD
Bosutinib—ULK3—lung—systemic lupus erythematosus	6.57e-05	0.00117	CbGeAlD
Bosutinib—MAP2K2—lung—systemic lupus erythematosus	6.57e-05	0.00117	CbGeAlD
Bosutinib—CSNK1A1—central nervous system—systemic lupus erythematosus	6.57e-05	0.00117	CbGeAlD
Bosutinib—PDGFRB—connective tissue—systemic lupus erythematosus	6.53e-05	0.00116	CbGeAlD
Bosutinib—HCK—central nervous system—systemic lupus erythematosus	6.53e-05	0.00116	CbGeAlD
Bosutinib—CLK1—central nervous system—systemic lupus erythematosus	6.53e-05	0.00116	CbGeAlD
Bosutinib—MAP3K2—lung—systemic lupus erythematosus	6.53e-05	0.00116	CbGeAlD
Bosutinib—EPHA2—tendon—systemic lupus erythematosus	6.5e-05	0.00116	CbGeAlD
Bosutinib—FYN—tendon—systemic lupus erythematosus	6.49e-05	0.00116	CbGeAlD
Bosutinib—SLK—bone marrow—systemic lupus erythematosus	6.47e-05	0.00115	CbGeAlD
Bosutinib—MAP3K7—lung—systemic lupus erythematosus	6.46e-05	0.00115	CbGeAlD
Bosutinib—PTK2B—nervous system—systemic lupus erythematosus	6.43e-05	0.00114	CbGeAlD
Bosutinib—EPHB4—bone marrow—systemic lupus erythematosus	6.42e-05	0.00114	CbGeAlD
Bosutinib—BMP2K—central nervous system—systemic lupus erythematosus	6.41e-05	0.00114	CbGeAlD
Bosutinib—CAMK2G—central nervous system—systemic lupus erythematosus	6.41e-05	0.00114	CbGeAlD
Bosutinib—TBK1—lung—systemic lupus erythematosus	6.39e-05	0.00114	CbGeAlD
Bosutinib—PTK2—lung—systemic lupus erythematosus	6.39e-05	0.00114	CbGeAlD
Bosutinib—LRRK2—central nervous system—systemic lupus erythematosus	6.35e-05	0.00113	CbGeAlD
Bosutinib—MAP4K5—tendon—systemic lupus erythematosus	6.34e-05	0.00113	CbGeAlD
Bosutinib—MAP3K3—tendon—systemic lupus erythematosus	6.34e-05	0.00113	CbGeAlD
Bosutinib—CSNK1E—nervous system—systemic lupus erythematosus	6.32e-05	0.00113	CbGeAlD
Bosutinib—FYN—bone marrow—systemic lupus erythematosus	6.29e-05	0.00112	CbGeAlD
Bosutinib—IRAK1—lung—systemic lupus erythematosus	6.27e-05	0.00112	CbGeAlD
Bosutinib—MAP2K5—cortex of kidney—systemic lupus erythematosus	6.25e-05	0.00111	CbGeAlD
Bosutinib—YES1—lymphoid tissue—systemic lupus erythematosus	6.23e-05	0.00111	CbGeAlD
Bosutinib—SIK1—nervous system—systemic lupus erythematosus	6.22e-05	0.00111	CbGeAlD
Bosutinib—IRAK4—nervous system—systemic lupus erythematosus	6.22e-05	0.00111	CbGeAlD
Bosutinib—PTK2B—central nervous system—systemic lupus erythematosus	6.19e-05	0.0011	CbGeAlD
Bosutinib—STK10—lymphoid tissue—systemic lupus erythematosus	6.18e-05	0.0011	CbGeAlD
Bosutinib—Vandetanib—ALB—systemic lupus erythematosus	6.17e-05	0.0275	CrCbGaD
Bosutinib—EPHA4—nervous system—systemic lupus erythematosus	6.16e-05	0.0011	CbGeAlD
Bosutinib—TAOK3—lymphoid tissue—systemic lupus erythematosus	6.15e-05	0.0011	CbGeAlD
Bosutinib—RPS6KB1—lung—systemic lupus erythematosus	6.15e-05	0.00109	CbGeAlD
Bosutinib—MAP3K3—bone marrow—systemic lupus erythematosus	6.14e-05	0.00109	CbGeAlD
Bosutinib—MAP4K5—bone marrow—systemic lupus erythematosus	6.14e-05	0.00109	CbGeAlD
Bosutinib—LCK—lung—systemic lupus erythematosus	6.11e-05	0.00109	CbGeAlD
Bosutinib—FGR—lung—systemic lupus erythematosus	6.11e-05	0.00109	CbGeAlD
Bosutinib—ERBB3—nervous system—systemic lupus erythematosus	6.1e-05	0.00109	CbGeAlD
Bosutinib—CSNK1E—central nervous system—systemic lupus erythematosus	6.09e-05	0.00108	CbGeAlD
Bosutinib—ULK3—nervous system—systemic lupus erythematosus	6.09e-05	0.00108	CbGeAlD
Bosutinib—MAP2K2—nervous system—systemic lupus erythematosus	6.09e-05	0.00108	CbGeAlD
Bosutinib—AXL—lung—systemic lupus erythematosus	6.09e-05	0.00108	CbGeAlD
Bosutinib—MAP3K2—nervous system—systemic lupus erythematosus	6.04e-05	0.00108	CbGeAlD
Bosutinib—SRC—lymphoid tissue—systemic lupus erythematosus	5.99e-05	0.00107	CbGeAlD
Bosutinib—SIK1—central nervous system—systemic lupus erythematosus	5.99e-05	0.00107	CbGeAlD
Bosutinib—IRAK4—central nervous system—systemic lupus erythematosus	5.99e-05	0.00107	CbGeAlD
Bosutinib—EPHA4—central nervous system—systemic lupus erythematosus	5.93e-05	0.00106	CbGeAlD
Bosutinib—TBK1—nervous system—systemic lupus erythematosus	5.92e-05	0.00105	CbGeAlD
Bosutinib—PTK2—nervous system—systemic lupus erythematosus	5.92e-05	0.00105	CbGeAlD
Bosutinib—PDGFRB—skin of body—systemic lupus erythematosus	5.89e-05	0.00105	CbGeAlD
Bosutinib—ERBB3—central nervous system—systemic lupus erythematosus	5.87e-05	0.00105	CbGeAlD
Bosutinib—Gefitinib—ALB—systemic lupus erythematosus	5.86e-05	0.0261	CrCbGaD
Bosutinib—MAP2K2—central nervous system—systemic lupus erythematosus	5.86e-05	0.00104	CbGeAlD
Bosutinib—ULK3—central nervous system—systemic lupus erythematosus	5.86e-05	0.00104	CbGeAlD
Bosutinib—SLK—lung—systemic lupus erythematosus	5.86e-05	0.00104	CbGeAlD
Bosutinib—YES1—tendon—systemic lupus erythematosus	5.86e-05	0.00104	CbGeAlD
Bosutinib—ABL1—connective tissue—systemic lupus erythematosus	5.82e-05	0.00104	CbGeAlD
Bosutinib—MAP3K2—central nervous system—systemic lupus erythematosus	5.82e-05	0.00104	CbGeAlD
Bosutinib—EPHB4—lung—systemic lupus erythematosus	5.82e-05	0.00104	CbGeAlD
Bosutinib—STK10—tendon—systemic lupus erythematosus	5.8e-05	0.00103	CbGeAlD
Bosutinib—TAOK3—tendon—systemic lupus erythematosus	5.78e-05	0.00103	CbGeAlD
Bosutinib—EPHA2—lung—systemic lupus erythematosus	5.71e-05	0.00102	CbGeAlD
Bosutinib—PTK2—central nervous system—systemic lupus erythematosus	5.7e-05	0.00101	CbGeAlD
Bosutinib—TBK1—central nervous system—systemic lupus erythematosus	5.7e-05	0.00101	CbGeAlD
Bosutinib—FYN—lung—systemic lupus erythematosus	5.7e-05	0.00101	CbGeAlD
Bosutinib—RPS6KB1—nervous system—systemic lupus erythematosus	5.69e-05	0.00101	CbGeAlD
Bosutinib—YES1—bone marrow—systemic lupus erythematosus	5.67e-05	0.00101	CbGeAlD
Bosutinib—FGR—nervous system—systemic lupus erythematosus	5.66e-05	0.00101	CbGeAlD
Bosutinib—ABL1—nephron tubule—systemic lupus erythematosus	5.64e-05	0.001	CbGeAlD
Bosutinib—AXL—nervous system—systemic lupus erythematosus	5.64e-05	0.001	CbGeAlD
Bosutinib—STK10—bone marrow—systemic lupus erythematosus	5.62e-05	0.001	CbGeAlD
Bosutinib—TAOK3—bone marrow—systemic lupus erythematosus	5.6e-05	0.000997	CbGeAlD
Bosutinib—MAP4K5—lung—systemic lupus erythematosus	5.57e-05	0.000991	CbGeAlD
Bosutinib—MAP3K3—lung—systemic lupus erythematosus	5.57e-05	0.000991	CbGeAlD
Bosutinib—PDGFRB—kidney—systemic lupus erythematosus	5.56e-05	0.000989	CbGeAlD
Bosutinib—RPS6KB1—central nervous system—systemic lupus erythematosus	5.48e-05	0.000976	CbGeAlD
Bosutinib—FGR—central nervous system—systemic lupus erythematosus	5.45e-05	0.00097	CbGeAlD
Bosutinib—AXL—central nervous system—systemic lupus erythematosus	5.43e-05	0.000966	CbGeAlD
Bosutinib—PDGFRB—cortex of kidney—systemic lupus erythematosus	5.41e-05	0.000963	CbGeAlD
Bosutinib—CSF1R—lymphoid tissue—systemic lupus erythematosus	5.38e-05	0.000958	CbGeAlD
Bosutinib—EPHA2—nervous system—systemic lupus erythematosus	5.28e-05	0.000941	CbGeAlD
Bosutinib—FYN—nervous system—systemic lupus erythematosus	5.27e-05	0.000939	CbGeAlD
Bosutinib—ABL1—skin of body—systemic lupus erythematosus	5.25e-05	0.000935	CbGeAlD
Bosutinib—MAP2K5—tendon—systemic lupus erythematosus	5.18e-05	0.000923	CbGeAlD
Bosutinib—MAP4K5—nervous system—systemic lupus erythematosus	5.15e-05	0.000918	CbGeAlD
Bosutinib—MAP3K3—nervous system—systemic lupus erythematosus	5.15e-05	0.000918	CbGeAlD
Bosutinib—YES1—lung—systemic lupus erythematosus	5.14e-05	0.000915	CbGeAlD
Bosutinib—STK10—lung—systemic lupus erythematosus	5.09e-05	0.000907	CbGeAlD
Bosutinib—EPHA2—central nervous system—systemic lupus erythematosus	5.09e-05	0.000906	CbGeAlD
Bosutinib—FYN—central nervous system—systemic lupus erythematosus	5.08e-05	0.000904	CbGeAlD
Bosutinib—TAOK3—lung—systemic lupus erythematosus	5.07e-05	0.000903	CbGeAlD
Bosutinib—CSF1R—tendon—systemic lupus erythematosus	5.06e-05	0.000901	CbGeAlD
Bosutinib—MAP4K5—central nervous system—systemic lupus erythematosus	4.96e-05	0.000883	CbGeAlD
Bosutinib—MAP3K3—central nervous system—systemic lupus erythematosus	4.96e-05	0.000883	CbGeAlD
Bosutinib—ABL1—kidney—systemic lupus erythematosus	4.95e-05	0.000882	CbGeAlD
Bosutinib—SRC—lung—systemic lupus erythematosus	4.95e-05	0.00088	CbGeAlD
Bosutinib—CSF1R—bone marrow—systemic lupus erythematosus	4.9e-05	0.000872	CbGeAlD
Bosutinib—ABL1—cortex of kidney—systemic lupus erythematosus	4.82e-05	0.000859	CbGeAlD
Bosutinib—CYP3A4—blood plasma—systemic lupus erythematosus	4.8e-05	0.000855	CbGeAlD
Bosutinib—PDGFRB—lymphoid tissue—systemic lupus erythematosus	4.77e-05	0.00085	CbGeAlD
Bosutinib—YES1—nervous system—systemic lupus erythematosus	4.76e-05	0.000847	CbGeAlD
Bosutinib—STK10—nervous system—systemic lupus erythematosus	4.72e-05	0.00084	CbGeAlD
Bosutinib—TAOK3—nervous system—systemic lupus erythematosus	4.7e-05	0.000837	CbGeAlD
Bosutinib—YES1—central nervous system—systemic lupus erythematosus	4.58e-05	0.000816	CbGeAlD
Bosutinib—SRC—nervous system—systemic lupus erythematosus	4.58e-05	0.000815	CbGeAlD
Bosutinib—Infestation—Methotrexate—systemic lupus erythematosus	4.56e-05	0.0011	CcSEcCtD
Bosutinib—Infestation NOS—Methotrexate—systemic lupus erythematosus	4.56e-05	0.0011	CcSEcCtD
Bosutinib—Rash—Azathioprine—systemic lupus erythematosus	4.56e-05	0.00109	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—systemic lupus erythematosus	4.55e-05	0.00109	CcSEcCtD
Bosutinib—Dermatitis—Azathioprine—systemic lupus erythematosus	4.55e-05	0.00109	CcSEcCtD
Bosutinib—MAP2K5—lung—systemic lupus erythematosus	4.55e-05	0.00081	CbGeAlD
Bosutinib—Gastrointestinal disorder—Cyclosporine—systemic lupus erythematosus	4.55e-05	0.00109	CcSEcCtD
Bosutinib—Skin disorder—Hydrocortisone—systemic lupus erythematosus	4.55e-05	0.00109	CcSEcCtD
Bosutinib—Ill-defined disorder—Dexamethasone—systemic lupus erythematosus	4.55e-05	0.00109	CcSEcCtD
Bosutinib—Ill-defined disorder—Betamethasone—systemic lupus erythematosus	4.55e-05	0.00109	CcSEcCtD
Bosutinib—STK10—central nervous system—systemic lupus erythematosus	4.54e-05	0.000809	CbGeAlD
Bosutinib—Discomfort—Triamcinolone—systemic lupus erythematosus	4.54e-05	0.00109	CcSEcCtD
Bosutinib—Fatigue—Cyclosporine—systemic lupus erythematosus	4.54e-05	0.00109	CcSEcCtD
Bosutinib—Discomfort—Methylprednisolone—systemic lupus erythematosus	4.53e-05	0.00109	CcSEcCtD
Bosutinib—Headache—Azathioprine—systemic lupus erythematosus	4.53e-05	0.00109	CcSEcCtD
Bosutinib—TAOK3—central nervous system—systemic lupus erythematosus	4.52e-05	0.000805	CbGeAlD
Bosutinib—Dizziness—Leflunomide—systemic lupus erythematosus	4.51e-05	0.00108	CcSEcCtD
Bosutinib—Pain—Cyclosporine—systemic lupus erythematosus	4.5e-05	0.00108	CcSEcCtD
Bosutinib—PDGFRB—tendon—systemic lupus erythematosus	4.49e-05	0.000799	CbGeAlD
Bosutinib—Renal failure—Methotrexate—systemic lupus erythematosus	4.48e-05	0.00108	CcSEcCtD
Bosutinib—Decreased appetite—Mycophenolate mofetil—systemic lupus erythematosus	4.47e-05	0.00107	CcSEcCtD
Bosutinib—CSF1R—lung—systemic lupus erythematosus	4.44e-05	0.00079	CbGeAlD
Bosutinib—Gastrointestinal disorder—Mycophenolate mofetil—systemic lupus erythematosus	4.43e-05	0.00107	CcSEcCtD
Bosutinib—Immune system disorder—Prednisone—systemic lupus erythematosus	4.43e-05	0.00106	CcSEcCtD
Bosutinib—Malaise—Dexamethasone—systemic lupus erythematosus	4.42e-05	0.00106	CcSEcCtD
Bosutinib—Malaise—Betamethasone—systemic lupus erythematosus	4.42e-05	0.00106	CcSEcCtD
Bosutinib—SRC—central nervous system—systemic lupus erythematosus	4.41e-05	0.000785	CbGeAlD
Bosutinib—Anaphylactic shock—Triamcinolone—systemic lupus erythematosus	4.41e-05	0.00106	CcSEcCtD
Bosutinib—Oedema—Triamcinolone—systemic lupus erythematosus	4.41e-05	0.00106	CcSEcCtD
Bosutinib—Anaphylactic shock—Methylprednisolone—systemic lupus erythematosus	4.4e-05	0.00106	CcSEcCtD
Bosutinib—Pain—Mycophenolate mofetil—systemic lupus erythematosus	4.39e-05	0.00106	CcSEcCtD
Bosutinib—Infection—Triamcinolone—systemic lupus erythematosus	4.38e-05	0.00105	CcSEcCtD
Bosutinib—Infection—Methylprednisolone—systemic lupus erythematosus	4.37e-05	0.00105	CcSEcCtD
Bosutinib—PDGFRB—bone marrow—systemic lupus erythematosus	4.35e-05	0.000774	CbGeAlD
Bosutinib—Feeling abnormal—Cyclosporine—systemic lupus erythematosus	4.34e-05	0.00104	CcSEcCtD
Bosutinib—Vomiting—Leflunomide—systemic lupus erythematosus	4.34e-05	0.00104	CcSEcCtD
Bosutinib—Hepatobiliary disease—Methotrexate—systemic lupus erythematosus	4.31e-05	0.00104	CcSEcCtD
Bosutinib—Nervous system disorder—Methylprednisolone—systemic lupus erythematosus	4.31e-05	0.00104	CcSEcCtD
Bosutinib—Gastrointestinal pain—Cyclosporine—systemic lupus erythematosus	4.31e-05	0.00103	CcSEcCtD
Bosutinib—Rash—Leflunomide—systemic lupus erythematosus	4.3e-05	0.00103	CcSEcCtD
Bosutinib—Dermatitis—Leflunomide—systemic lupus erythematosus	4.3e-05	0.00103	CcSEcCtD
Bosutinib—Nausea—Azathioprine—systemic lupus erythematosus	4.29e-05	0.00103	CcSEcCtD
Bosutinib—Headache—Leflunomide—systemic lupus erythematosus	4.27e-05	0.00103	CcSEcCtD
Bosutinib—Skin disorder—Methylprednisolone—systemic lupus erythematosus	4.27e-05	0.00103	CcSEcCtD
Bosutinib—Malnutrition—Prednisone—systemic lupus erythematosus	4.27e-05	0.00103	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Hydrocortisone—systemic lupus erythematosus	4.26e-05	0.00102	CcSEcCtD
Bosutinib—Agranulocytosis—Methotrexate—systemic lupus erythematosus	4.26e-05	0.00102	CcSEcCtD
Bosutinib—ABL1—lymphoid tissue—systemic lupus erythematosus	4.25e-05	0.000757	CbGeAlD
Bosutinib—Feeling abnormal—Mycophenolate mofetil—systemic lupus erythematosus	4.23e-05	0.00102	CcSEcCtD
Bosutinib—MAP2K5—nervous system—systemic lupus erythematosus	4.21e-05	0.00075	CbGeAlD
Bosutinib—Gastrointestinal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.2e-05	0.00101	CcSEcCtD
Bosutinib—Urticaria—Cyclosporine—systemic lupus erythematosus	4.18e-05	0.00101	CcSEcCtD
Bosutinib—Myalgia—Dexamethasone—systemic lupus erythematosus	4.17e-05	0.001	CcSEcCtD
Bosutinib—Myalgia—Betamethasone—systemic lupus erythematosus	4.17e-05	0.001	CcSEcCtD
Bosutinib—Abdominal pain—Cyclosporine—systemic lupus erythematosus	4.16e-05	0.001	CcSEcCtD
Bosutinib—Body temperature increased—Cyclosporine—systemic lupus erythematosus	4.16e-05	0.001	CcSEcCtD
Bosutinib—Discomfort—Dexamethasone—systemic lupus erythematosus	4.12e-05	0.00099	CcSEcCtD
Bosutinib—Discomfort—Betamethasone—systemic lupus erythematosus	4.12e-05	0.00099	CcSEcCtD
Bosutinib—CSF1R—nervous system—systemic lupus erythematosus	4.11e-05	0.000732	CbGeAlD
Bosutinib—Pain—Prednisolone—systemic lupus erythematosus	4.1e-05	0.000985	CcSEcCtD
Bosutinib—Hepatitis—Methotrexate—systemic lupus erythematosus	4.1e-05	0.000984	CcSEcCtD
Bosutinib—Urticaria—Mycophenolate mofetil—systemic lupus erythematosus	4.08e-05	0.000981	CcSEcCtD
Bosutinib—Decreased appetite—Hydrocortisone—systemic lupus erythematosus	4.07e-05	0.000978	CcSEcCtD
Bosutinib—Abdominal pain—Mycophenolate mofetil—systemic lupus erythematosus	4.06e-05	0.000976	CcSEcCtD
Bosutinib—Body temperature increased—Mycophenolate mofetil—systemic lupus erythematosus	4.06e-05	0.000976	CcSEcCtD
Bosutinib—MAP2K5—central nervous system—systemic lupus erythematosus	4.06e-05	0.000722	CbGeAlD
Bosutinib—Nausea—Leflunomide—systemic lupus erythematosus	4.05e-05	0.000974	CcSEcCtD
Bosutinib—Urinary tract disorder—Methotrexate—systemic lupus erythematosus	4.04e-05	0.000972	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Hydrocortisone—systemic lupus erythematosus	4.04e-05	0.000971	CcSEcCtD
Bosutinib—Fatigue—Hydrocortisone—systemic lupus erythematosus	4.03e-05	0.00097	CcSEcCtD
Bosutinib—Urethral disorder—Methotrexate—systemic lupus erythematosus	4.01e-05	0.000965	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	4.01e-05	0.000965	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	4.01e-05	0.000963	CcSEcCtD
Bosutinib—Pain—Hydrocortisone—systemic lupus erythematosus	4e-05	0.000962	CcSEcCtD
Bosutinib—ABL1—tendon—systemic lupus erythematosus	4e-05	0.000712	CbGeAlD
Bosutinib—Anaphylactic shock—Betamethasone—systemic lupus erythematosus	4e-05	0.000961	CcSEcCtD
Bosutinib—Anaphylactic shock—Dexamethasone—systemic lupus erythematosus	4e-05	0.000961	CcSEcCtD
Bosutinib—Oedema—Dexamethasone—systemic lupus erythematosus	4e-05	0.000961	CcSEcCtD
Bosutinib—Oedema—Betamethasone—systemic lupus erythematosus	4e-05	0.000961	CcSEcCtD
Bosutinib—Infection—Dexamethasone—systemic lupus erythematosus	3.97e-05	0.000955	CcSEcCtD
Bosutinib—Infection—Betamethasone—systemic lupus erythematosus	3.97e-05	0.000955	CcSEcCtD
Bosutinib—Ill-defined disorder—Prednisone—systemic lupus erythematosus	3.96e-05	0.000951	CcSEcCtD
Bosutinib—CSF1R—central nervous system—systemic lupus erythematosus	3.96e-05	0.000705	CbGeAlD
Bosutinib—Feeling abnormal—Prednisolone—systemic lupus erythematosus	3.95e-05	0.000949	CcSEcCtD
Bosutinib—Anaemia—Prednisone—systemic lupus erythematosus	3.94e-05	0.000948	CcSEcCtD
Bosutinib—PDGFRB—lung—systemic lupus erythematosus	3.94e-05	0.000701	CbGeAlD
Bosutinib—Dyspnoea—Triamcinolone—systemic lupus erythematosus	3.93e-05	0.000944	CcSEcCtD
Bosutinib—Nervous system disorder—Betamethasone—systemic lupus erythematosus	3.92e-05	0.000942	CcSEcCtD
Bosutinib—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	3.92e-05	0.000942	CcSEcCtD
Bosutinib—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	3.91e-05	0.000941	CcSEcCtD
Bosutinib—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	3.91e-05	0.000941	CcSEcCtD
Bosutinib—ABL1—bone marrow—systemic lupus erythematosus	3.87e-05	0.00069	CbGeAlD
Bosutinib—Erythema multiforme—Methotrexate—systemic lupus erythematosus	3.87e-05	0.000931	CcSEcCtD
Bosutinib—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	3.86e-05	0.000927	CcSEcCtD
Bosutinib—Malaise—Prednisone—systemic lupus erythematosus	3.85e-05	0.000925	CcSEcCtD
Bosutinib—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	3.83e-05	0.00092	CcSEcCtD
Bosutinib—Tinnitus—Methotrexate—systemic lupus erythematosus	3.82e-05	0.000918	CcSEcCtD
Bosutinib—Urticaria—Prednisolone—systemic lupus erythematosus	3.81e-05	0.000915	CcSEcCtD
Bosutinib—Cardiac disorder—Methotrexate—systemic lupus erythematosus	3.8e-05	0.000914	CcSEcCtD
Bosutinib—Fatigue—Triamcinolone—systemic lupus erythematosus	3.8e-05	0.000913	CcSEcCtD
Bosutinib—Fatigue—Methylprednisolone—systemic lupus erythematosus	3.79e-05	0.000911	CcSEcCtD
Bosutinib—Asthenia—Cyclosporine—systemic lupus erythematosus	3.78e-05	0.000908	CcSEcCtD
Bosutinib—Pain—Triamcinolone—systemic lupus erythematosus	3.77e-05	0.000906	CcSEcCtD
Bosutinib—Pruritus—Cyclosporine—systemic lupus erythematosus	3.73e-05	0.000895	CcSEcCtD
Bosutinib—Urticaria—Hydrocortisone—systemic lupus erythematosus	3.72e-05	0.000893	CcSEcCtD
Bosutinib—Immune system disorder—Methotrexate—systemic lupus erythematosus	3.7e-05	0.000889	CcSEcCtD
Bosutinib—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	3.7e-05	0.000889	CcSEcCtD
Bosutinib—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	3.7e-05	0.000889	CcSEcCtD
Bosutinib—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	3.69e-05	0.000887	CcSEcCtD
Bosutinib—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	3.69e-05	0.000886	CcSEcCtD
Bosutinib—PDGFRB—nervous system—systemic lupus erythematosus	3.65e-05	0.000649	CbGeAlD
Bosutinib—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	3.64e-05	0.000875	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	3.64e-05	0.000875	CcSEcCtD
Bosutinib—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	3.63e-05	0.000873	CcSEcCtD
Bosutinib—Myalgia—Prednisone—systemic lupus erythematosus	3.63e-05	0.000873	CcSEcCtD
Bosutinib—Arthralgia—Prednisone—systemic lupus erythematosus	3.63e-05	0.000873	CcSEcCtD
Bosutinib—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	3.63e-05	0.000873	CcSEcCtD
Bosutinib—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	3.62e-05	0.000871	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	3.61e-05	0.000867	CcSEcCtD
Bosutinib—Diarrhoea—Cyclosporine—systemic lupus erythematosus	3.6e-05	0.000866	CcSEcCtD
Bosutinib—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	3.6e-05	0.000864	CcSEcCtD
Bosutinib—Discomfort—Prednisone—systemic lupus erythematosus	3.59e-05	0.000862	CcSEcCtD
Bosutinib—Malnutrition—Methotrexate—systemic lupus erythematosus	3.57e-05	0.000857	CcSEcCtD
Bosutinib—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	3.51e-05	0.000845	CcSEcCtD
Bosutinib—PDGFRB—central nervous system—systemic lupus erythematosus	3.51e-05	0.000625	CbGeAlD
Bosutinib—ABL1—lung—systemic lupus erythematosus	3.51e-05	0.000625	CbGeAlD
Bosutinib—Urticaria—Triamcinolone—systemic lupus erythematosus	3.5e-05	0.000841	CcSEcCtD
Bosutinib—Urticaria—Methylprednisolone—systemic lupus erythematosus	3.49e-05	0.000839	CcSEcCtD
Bosutinib—Dysgeusia—Methotrexate—systemic lupus erythematosus	3.49e-05	0.000839	CcSEcCtD
Bosutinib—Body temperature increased—Triamcinolone—systemic lupus erythematosus	3.48e-05	0.000837	CcSEcCtD
Bosutinib—Dizziness—Cyclosporine—systemic lupus erythematosus	3.48e-05	0.000837	CcSEcCtD
Bosutinib—Oedema—Prednisone—systemic lupus erythematosus	3.48e-05	0.000837	CcSEcCtD
Bosutinib—Anaphylactic shock—Prednisone—systemic lupus erythematosus	3.48e-05	0.000837	CcSEcCtD
Bosutinib—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	3.48e-05	0.000835	CcSEcCtD
Bosutinib—Decreased appetite—Dexamethasone—systemic lupus erythematosus	3.48e-05	0.000835	CcSEcCtD
Bosutinib—Decreased appetite—Betamethasone—systemic lupus erythematosus	3.48e-05	0.000835	CcSEcCtD
Bosutinib—Infection—Prednisone—systemic lupus erythematosus	3.46e-05	0.000831	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	3.45e-05	0.00083	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	3.45e-05	0.00083	CcSEcCtD
Bosutinib—Back pain—Methotrexate—systemic lupus erythematosus	3.45e-05	0.000829	CcSEcCtD
Bosutinib—Fatigue—Betamethasone—systemic lupus erythematosus	3.45e-05	0.000828	CcSEcCtD
Bosutinib—Fatigue—Dexamethasone—systemic lupus erythematosus	3.45e-05	0.000828	CcSEcCtD
Bosutinib—PLK2—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	3.42e-05	0.019	CbGdCrCtD
Bosutinib—Pain—Dexamethasone—systemic lupus erythematosus	3.42e-05	0.000822	CcSEcCtD
Bosutinib—Pain—Betamethasone—systemic lupus erythematosus	3.42e-05	0.000822	CcSEcCtD
Bosutinib—Nervous system disorder—Prednisone—systemic lupus erythematosus	3.41e-05	0.000821	CcSEcCtD
Bosutinib—ABCB1—blood plasma—systemic lupus erythematosus	3.4e-05	0.000605	CbGeAlD
Bosutinib—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	3.4e-05	0.000816	CcSEcCtD
Bosutinib—Skin disorder—Prednisone—systemic lupus erythematosus	3.38e-05	0.000813	CcSEcCtD
Bosutinib—Asthenia—Hydrocortisone—systemic lupus erythematosus	3.36e-05	0.000807	CcSEcCtD
Bosutinib—Vomiting—Cyclosporine—systemic lupus erythematosus	3.35e-05	0.000805	CcSEcCtD
Bosutinib—Rash—Cyclosporine—systemic lupus erythematosus	3.32e-05	0.000798	CcSEcCtD
Bosutinib—Dermatitis—Cyclosporine—systemic lupus erythematosus	3.32e-05	0.000797	CcSEcCtD
Bosutinib—Pruritus—Hydrocortisone—systemic lupus erythematosus	3.31e-05	0.000796	CcSEcCtD
Bosutinib—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	3.31e-05	0.000795	CcSEcCtD
Bosutinib—MAP4K4—Testosterone Propionate—Hydrocortisone—systemic lupus erythematosus	3.3e-05	0.0183	CbGdCrCtD
Bosutinib—Headache—Cyclosporine—systemic lupus erythematosus	3.3e-05	0.000793	CcSEcCtD
Bosutinib—Anaemia—Methotrexate—systemic lupus erythematosus	3.3e-05	0.000792	CcSEcCtD
Bosutinib—Feeling abnormal—Betamethasone—systemic lupus erythematosus	3.29e-05	0.000792	CcSEcCtD
Bosutinib—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	3.29e-05	0.000792	CcSEcCtD
Bosutinib—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	3.27e-05	0.000786	CcSEcCtD
Bosutinib—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	3.27e-05	0.000786	CcSEcCtD
Bosutinib—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	3.27e-05	0.000785	CcSEcCtD
Bosutinib—ABL1—nervous system—systemic lupus erythematosus	3.25e-05	0.000579	CbGeAlD
Bosutinib—Rash—Mycophenolate mofetil—systemic lupus erythematosus	3.24e-05	0.000778	CcSEcCtD
Bosutinib—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	3.24e-05	0.000778	CcSEcCtD
Bosutinib—Headache—Mycophenolate mofetil—systemic lupus erythematosus	3.22e-05	0.000773	CcSEcCtD
Bosutinib—Malaise—Methotrexate—systemic lupus erythematosus	3.22e-05	0.000773	CcSEcCtD
Bosutinib—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	3.2e-05	0.000769	CcSEcCtD
Bosutinib—Leukopenia—Methotrexate—systemic lupus erythematosus	3.19e-05	0.000767	CcSEcCtD
Bosutinib—Urticaria—Betamethasone—systemic lupus erythematosus	3.18e-05	0.000763	CcSEcCtD
Bosutinib—Urticaria—Dexamethasone—systemic lupus erythematosus	3.18e-05	0.000763	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	3.17e-05	0.000762	CcSEcCtD
Bosutinib—Dizziness—Prednisolone—systemic lupus erythematosus	3.17e-05	0.000761	CcSEcCtD
Bosutinib—Asthenia—Triamcinolone—systemic lupus erythematosus	3.16e-05	0.00076	CcSEcCtD
Bosutinib—Body temperature increased—Betamethasone—systemic lupus erythematosus	3.16e-05	0.00076	CcSEcCtD
Bosutinib—Body temperature increased—Dexamethasone—systemic lupus erythematosus	3.16e-05	0.00076	CcSEcCtD
Bosutinib—Abdominal pain—Betamethasone—systemic lupus erythematosus	3.16e-05	0.00076	CcSEcCtD
Bosutinib—Abdominal pain—Dexamethasone—systemic lupus erythematosus	3.16e-05	0.00076	CcSEcCtD
Bosutinib—Asthenia—Methylprednisolone—systemic lupus erythematosus	3.15e-05	0.000758	CcSEcCtD
Bosutinib—ABL1—central nervous system—systemic lupus erythematosus	3.13e-05	0.000557	CbGeAlD
Bosutinib—Nausea—Cyclosporine—systemic lupus erythematosus	3.13e-05	0.000752	CcSEcCtD
Bosutinib—Pruritus—Triamcinolone—systemic lupus erythematosus	3.12e-05	0.000749	CcSEcCtD
Bosutinib—Cough—Methotrexate—systemic lupus erythematosus	3.11e-05	0.000748	CcSEcCtD
Bosutinib—Pruritus—Methylprednisolone—systemic lupus erythematosus	3.11e-05	0.000748	CcSEcCtD
Bosutinib—Dizziness—Hydrocortisone—systemic lupus erythematosus	3.09e-05	0.000744	CcSEcCtD
Bosutinib—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	3.05e-05	0.000733	CcSEcCtD
Bosutinib—Chest pain—Methotrexate—systemic lupus erythematosus	3.04e-05	0.000729	CcSEcCtD
Bosutinib—Arthralgia—Methotrexate—systemic lupus erythematosus	3.04e-05	0.000729	CcSEcCtD
Bosutinib—Myalgia—Methotrexate—systemic lupus erythematosus	3.04e-05	0.000729	CcSEcCtD
Bosutinib—Decreased appetite—Prednisone—systemic lupus erythematosus	3.03e-05	0.000727	CcSEcCtD
Bosutinib—Rash—Prednisolone—systemic lupus erythematosus	3.02e-05	0.000726	CcSEcCtD
Bosutinib—Dermatitis—Prednisolone—systemic lupus erythematosus	3.02e-05	0.000725	CcSEcCtD
Bosutinib—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	3.01e-05	0.000724	CcSEcCtD
Bosutinib—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	3.01e-05	0.000723	CcSEcCtD
Bosutinib—Fatigue—Prednisone—systemic lupus erythematosus	3e-05	0.000721	CcSEcCtD
Bosutinib—Headache—Prednisolone—systemic lupus erythematosus	3e-05	0.000721	CcSEcCtD
Bosutinib—Discomfort—Methotrexate—systemic lupus erythematosus	3e-05	0.000721	CcSEcCtD
Bosutinib—Vomiting—Hydrocortisone—systemic lupus erythematosus	2.98e-05	0.000715	CcSEcCtD
Bosutinib—Rash—Hydrocortisone—systemic lupus erythematosus	2.95e-05	0.000709	CcSEcCtD
Bosutinib—Dermatitis—Hydrocortisone—systemic lupus erythematosus	2.95e-05	0.000708	CcSEcCtD
Bosutinib—Headache—Hydrocortisone—systemic lupus erythematosus	2.93e-05	0.000705	CcSEcCtD
Bosutinib—Dizziness—Triamcinolone—systemic lupus erythematosus	2.91e-05	0.0007	CcSEcCtD
Bosutinib—Anaphylactic shock—Methotrexate—systemic lupus erythematosus	2.91e-05	0.000699	CcSEcCtD
Bosutinib—Dizziness—Methylprednisolone—systemic lupus erythematosus	2.91e-05	0.000699	CcSEcCtD
Bosutinib—Infection—Methotrexate—systemic lupus erythematosus	2.89e-05	0.000695	CcSEcCtD
Bosutinib—Feeling abnormal—Prednisone—systemic lupus erythematosus	2.87e-05	0.00069	CcSEcCtD
Bosutinib—Asthenia—Dexamethasone—systemic lupus erythematosus	2.87e-05	0.000689	CcSEcCtD
Bosutinib—Asthenia—Betamethasone—systemic lupus erythematosus	2.87e-05	0.000689	CcSEcCtD
Bosutinib—Nervous system disorder—Methotrexate—systemic lupus erythematosus	2.85e-05	0.000686	CcSEcCtD
Bosutinib—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	2.85e-05	0.000685	CcSEcCtD
Bosutinib—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	2.85e-05	0.000684	CcSEcCtD
Bosutinib—Nausea—Prednisolone—systemic lupus erythematosus	2.85e-05	0.000684	CcSEcCtD
Bosutinib—Pruritus—Betamethasone—systemic lupus erythematosus	2.83e-05	0.00068	CcSEcCtD
Bosutinib—Pruritus—Dexamethasone—systemic lupus erythematosus	2.83e-05	0.00068	CcSEcCtD
Bosutinib—Skin disorder—Methotrexate—systemic lupus erythematosus	2.83e-05	0.000679	CcSEcCtD
Bosutinib—Vomiting—Triamcinolone—systemic lupus erythematosus	2.8e-05	0.000673	CcSEcCtD
Bosutinib—Vomiting—Methylprednisolone—systemic lupus erythematosus	2.8e-05	0.000672	CcSEcCtD
Bosutinib—Nausea—Hydrocortisone—systemic lupus erythematosus	2.78e-05	0.000668	CcSEcCtD
Bosutinib—Rash—Triamcinolone—systemic lupus erythematosus	2.78e-05	0.000668	CcSEcCtD
Bosutinib—Dermatitis—Triamcinolone—systemic lupus erythematosus	2.78e-05	0.000667	CcSEcCtD
Bosutinib—Rash—Methylprednisolone—systemic lupus erythematosus	2.77e-05	0.000666	CcSEcCtD
Bosutinib—Dermatitis—Methylprednisolone—systemic lupus erythematosus	2.77e-05	0.000666	CcSEcCtD
Bosutinib—Urticaria—Prednisone—systemic lupus erythematosus	2.77e-05	0.000665	CcSEcCtD
Bosutinib—Headache—Triamcinolone—systemic lupus erythematosus	2.76e-05	0.000663	CcSEcCtD
Bosutinib—Headache—Methylprednisolone—systemic lupus erythematosus	2.75e-05	0.000662	CcSEcCtD
Bosutinib—Abdominal pain—Prednisone—systemic lupus erythematosus	2.75e-05	0.000661	CcSEcCtD
Bosutinib—Body temperature increased—Prednisone—systemic lupus erythematosus	2.75e-05	0.000661	CcSEcCtD
Bosutinib—Diarrhoea—Dexamethasone—systemic lupus erythematosus	2.74e-05	0.000657	CcSEcCtD
Bosutinib—Diarrhoea—Betamethasone—systemic lupus erythematosus	2.74e-05	0.000657	CcSEcCtD
Bosutinib—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	2.65e-05	0.000637	CcSEcCtD
Bosutinib—Dizziness—Betamethasone—systemic lupus erythematosus	2.64e-05	0.000635	CcSEcCtD
Bosutinib—Dizziness—Dexamethasone—systemic lupus erythematosus	2.64e-05	0.000635	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Methylprednisolone—systemic lupus erythematosus	2.62e-05	0.0145	CbGdCrCtD
Bosutinib—Nausea—Triamcinolone—systemic lupus erythematosus	2.62e-05	0.000629	CcSEcCtD
Bosutinib—Nausea—Methylprednisolone—systemic lupus erythematosus	2.61e-05	0.000628	CcSEcCtD
Bosutinib—Dyspnoea—Methotrexate—systemic lupus erythematosus	2.59e-05	0.000623	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Betamethasone—systemic lupus erythematosus	2.58e-05	0.0143	CbGdCrCtD
Bosutinib—EPHB2—Diflorasone—Dexamethasone—systemic lupus erythematosus	2.58e-05	0.0143	CbGdCrCtD
Bosutinib—Vomiting—Betamethasone—systemic lupus erythematosus	2.54e-05	0.000611	CcSEcCtD
Bosutinib—Vomiting—Dexamethasone—systemic lupus erythematosus	2.54e-05	0.000611	CcSEcCtD
Bosutinib—Decreased appetite—Methotrexate—systemic lupus erythematosus	2.53e-05	0.000608	CcSEcCtD
Bosutinib—Rash—Dexamethasone—systemic lupus erythematosus	2.52e-05	0.000606	CcSEcCtD
Bosutinib—Rash—Betamethasone—systemic lupus erythematosus	2.52e-05	0.000606	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Triamcinolone—systemic lupus erythematosus	2.52e-05	0.014	CbGdCrCtD
Bosutinib—Dermatitis—Dexamethasone—systemic lupus erythematosus	2.52e-05	0.000605	CcSEcCtD
Bosutinib—Dermatitis—Betamethasone—systemic lupus erythematosus	2.52e-05	0.000605	CcSEcCtD
Bosutinib—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	2.51e-05	0.000604	CcSEcCtD
Bosutinib—Fatigue—Methotrexate—systemic lupus erythematosus	2.51e-05	0.000603	CcSEcCtD
Bosutinib—Headache—Betamethasone—systemic lupus erythematosus	2.5e-05	0.000602	CcSEcCtD
Bosutinib—Headache—Dexamethasone—systemic lupus erythematosus	2.5e-05	0.000602	CcSEcCtD
Bosutinib—Asthenia—Prednisone—systemic lupus erythematosus	2.5e-05	0.0006	CcSEcCtD
Bosutinib—Pain—Methotrexate—systemic lupus erythematosus	2.49e-05	0.000598	CcSEcCtD
Bosutinib—Pruritus—Prednisone—systemic lupus erythematosus	2.46e-05	0.000592	CcSEcCtD
Bosutinib—Feeling abnormal—Methotrexate—systemic lupus erythematosus	2.4e-05	0.000576	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Prednisone—systemic lupus erythematosus	2.39e-05	0.0133	CbGdCrCtD
Bosutinib—Diarrhoea—Prednisone—systemic lupus erythematosus	2.38e-05	0.000573	CcSEcCtD
Bosutinib—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	2.38e-05	0.000572	CcSEcCtD
Bosutinib—Nausea—Betamethasone—systemic lupus erythematosus	2.37e-05	0.000571	CcSEcCtD
Bosutinib—Nausea—Dexamethasone—systemic lupus erythematosus	2.37e-05	0.000571	CcSEcCtD
Bosutinib—EPHB2—Diflorasone—Prednisolone—systemic lupus erythematosus	2.33e-05	0.0129	CbGdCrCtD
Bosutinib—Urticaria—Methotrexate—systemic lupus erythematosus	2.31e-05	0.000556	CcSEcCtD
Bosutinib—Dizziness—Prednisone—systemic lupus erythematosus	2.3e-05	0.000553	CcSEcCtD
Bosutinib—Body temperature increased—Methotrexate—systemic lupus erythematosus	2.3e-05	0.000553	CcSEcCtD
Bosutinib—Abdominal pain—Methotrexate—systemic lupus erythematosus	2.3e-05	0.000553	CcSEcCtD
Bosutinib—Vomiting—Prednisone—systemic lupus erythematosus	2.21e-05	0.000532	CcSEcCtD
Bosutinib—Rash—Prednisone—systemic lupus erythematosus	2.2e-05	0.000528	CcSEcCtD
Bosutinib—Dermatitis—Prednisone—systemic lupus erythematosus	2.19e-05	0.000527	CcSEcCtD
Bosutinib—Headache—Prednisone—systemic lupus erythematosus	2.18e-05	0.000524	CcSEcCtD
Bosutinib—CYP3A4—kidney—systemic lupus erythematosus	2.18e-05	0.000387	CbGeAlD
Bosutinib—Asthenia—Methotrexate—systemic lupus erythematosus	2.09e-05	0.000502	CcSEcCtD
Bosutinib—Nausea—Prednisone—systemic lupus erythematosus	2.07e-05	0.000497	CcSEcCtD
Bosutinib—Pruritus—Methotrexate—systemic lupus erythematosus	2.06e-05	0.000495	CcSEcCtD
Bosutinib—Diarrhoea—Methotrexate—systemic lupus erythematosus	1.99e-05	0.000478	CcSEcCtD
Bosutinib—Dizziness—Methotrexate—systemic lupus erythematosus	1.92e-05	0.000462	CcSEcCtD
Bosutinib—Vomiting—Methotrexate—systemic lupus erythematosus	1.85e-05	0.000445	CcSEcCtD
Bosutinib—Rash—Methotrexate—systemic lupus erythematosus	1.83e-05	0.000441	CcSEcCtD
Bosutinib—Dermatitis—Methotrexate—systemic lupus erythematosus	1.83e-05	0.000441	CcSEcCtD
Bosutinib—Headache—Methotrexate—systemic lupus erythematosus	1.82e-05	0.000438	CcSEcCtD
Bosutinib—ABCB1—nephron tubule—systemic lupus erythematosus	1.75e-05	0.000312	CbGeAlD
Bosutinib—Nausea—Methotrexate—systemic lupus erythematosus	1.73e-05	0.000415	CcSEcCtD
Bosutinib—PKMYT1—Danazol—Hydrocortisone—systemic lupus erythematosus	1.58e-05	0.00874	CbGdCrCtD
Bosutinib—ABCB1—kidney—systemic lupus erythematosus	1.54e-05	0.000274	CbGeAlD
Bosutinib—CSNK1E—Danazol—Hydrocortisone—systemic lupus erythematosus	1.5e-05	0.00834	CbGdCrCtD
Bosutinib—ABCB1—cortex of kidney—systemic lupus erythematosus	1.5e-05	0.000267	CbGeAlD
Bosutinib—CYP3A4—nervous system—systemic lupus erythematosus	1.43e-05	0.000254	CbGeAlD
Bosutinib—CYP3A4—central nervous system—systemic lupus erythematosus	1.37e-05	0.000245	CbGeAlD
Bosutinib—PKMYT1—Danazol—Prednisone—systemic lupus erythematosus	1.36e-05	0.00753	CbGdCrCtD
Bosutinib—ABCB1—lymphoid tissue—systemic lupus erythematosus	1.32e-05	0.000235	CbGeAlD
Bosutinib—CSNK1E—Danazol—Prednisone—systemic lupus erythematosus	1.29e-05	0.00718	CbGdCrCtD
Bosutinib—ABCB1—bone marrow—systemic lupus erythematosus	1.2e-05	0.000214	CbGeAlD
Bosutinib—ABCB1—lung—systemic lupus erythematosus	1.09e-05	0.000194	CbGeAlD
Bosutinib—ABCB1—nervous system—systemic lupus erythematosus	1.01e-05	0.00018	CbGeAlD
Bosutinib—ABCB1—central nervous system—systemic lupus erythematosus	9.73e-06	0.000173	CbGeAlD
Bosutinib—CSNK1E—Dexamethasone—Hydrocortisone—systemic lupus erythematosus	9.6e-06	0.00532	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Hydrocortisone—systemic lupus erythematosus	9.6e-06	0.00532	CbGdCrCtD
Bosutinib—CHEK2—Testosterone Propionate—Hydrocortisone—systemic lupus erythematosus	9.26e-06	0.00513	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Methylprednisolone—systemic lupus erythematosus	9.05e-06	0.00502	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Methylprednisolone—systemic lupus erythematosus	9.05e-06	0.00502	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Dexamethasone—systemic lupus erythematosus	8.91e-06	0.00494	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Betamethasone—systemic lupus erythematosus	8.91e-06	0.00494	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Triamcinolone—systemic lupus erythematosus	8.71e-06	0.00483	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Triamcinolone—systemic lupus erythematosus	8.71e-06	0.00483	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Prednisone—systemic lupus erythematosus	8.26e-06	0.00458	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Prednisone—systemic lupus erythematosus	8.26e-06	0.00458	CbGdCrCtD
Bosutinib—CSNK1E—Dexamethasone—Prednisolone—systemic lupus erythematosus	8.07e-06	0.00447	CbGdCrCtD
Bosutinib—CSNK1E—Betamethasone—Prednisolone—systemic lupus erythematosus	8.07e-06	0.00447	CbGdCrCtD
Bosutinib—CHEK2—Danazol—Hydrocortisone—systemic lupus erythematosus	7.7e-06	0.00427	CbGdCrCtD
Bosutinib—CHEK2—Norethindrone—Hydrocortisone—systemic lupus erythematosus	6.93e-06	0.00385	CbGdCrCtD
Bosutinib—CHEK2—Danazol—Prednisone—systemic lupus erythematosus	6.63e-06	0.00368	CbGdCrCtD
Bosutinib—CHEK2—Levonorgestrel—Hydrocortisone—systemic lupus erythematosus	5.52e-06	0.00306	CbGdCrCtD
Bosutinib—MAP2K2—Disease—CDKN1A—systemic lupus erythematosus	3.8e-07	4.14e-06	CbGpPWpGaD
Bosutinib—CSK—Signaling Pathways—IL6—systemic lupus erythematosus	3.8e-07	4.14e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—TYK2—systemic lupus erythematosus	3.8e-07	4.13e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CD80—systemic lupus erythematosus	3.78e-07	4.12e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.77e-07	4.11e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.77e-07	4.11e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CD80—systemic lupus erythematosus	3.76e-07	4.1e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.75e-07	4.08e-06	CbGpPWpGaD
Bosutinib—ERBB3—Immune System—IL6—systemic lupus erythematosus	3.75e-07	4.08e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—EP300—systemic lupus erythematosus	3.75e-07	4.08e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—C3—systemic lupus erythematosus	3.74e-07	4.07e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CCL2—systemic lupus erythematosus	3.74e-07	4.07e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—EP300—systemic lupus erythematosus	3.73e-07	4.06e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—NOS3—systemic lupus erythematosus	3.73e-07	4.06e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—CD4—systemic lupus erythematosus	3.72e-07	4.05e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—CDKN1A—systemic lupus erythematosus	3.71e-07	4.04e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—EP300—systemic lupus erythematosus	3.7e-07	4.03e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.7e-07	4.03e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—EP300—systemic lupus erythematosus	3.69e-07	4.01e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL2—systemic lupus erythematosus	3.67e-07	4e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—EP300—systemic lupus erythematosus	3.67e-07	3.99e-06	CbGpPWpGaD
Bosutinib—ABCB1—Transmembrane transport of small molecules—ALB—systemic lupus erythematosus	3.65e-07	3.97e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.65e-07	3.97e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CCL2—systemic lupus erythematosus	3.65e-07	3.97e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—TYK2—systemic lupus erythematosus	3.64e-07	3.96e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.64e-07	3.96e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.64e-07	3.96e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CDKN1B—systemic lupus erythematosus	3.63e-07	3.95e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—EP300—systemic lupus erythematosus	3.62e-07	3.94e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL2—systemic lupus erythematosus	3.62e-07	3.94e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.6e-07	3.91e-06	CbGpPWpGaD
Bosutinib—EGFR—Innate Immune System—IL6—systemic lupus erythematosus	3.58e-07	3.9e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—CDKN1A—systemic lupus erythematosus	3.58e-07	3.9e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—JAK1—systemic lupus erythematosus	3.58e-07	3.89e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CCL2—systemic lupus erythematosus	3.57e-07	3.89e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—CD4—systemic lupus erythematosus	3.56e-07	3.88e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—CDKN1A—systemic lupus erythematosus	3.56e-07	3.87e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL2—systemic lupus erythematosus	3.55e-07	3.87e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—PTGS2—systemic lupus erythematosus	3.54e-07	3.85e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—EP300—systemic lupus erythematosus	3.53e-07	3.85e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CCL2—systemic lupus erythematosus	3.52e-07	3.83e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.51e-07	3.82e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.5e-07	3.81e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CCL2—systemic lupus erythematosus	3.5e-07	3.81e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—CDKN1B—systemic lupus erythematosus	3.5e-07	3.81e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—MMP9—systemic lupus erythematosus	3.47e-07	3.78e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.46e-07	3.77e-06	CbGpPWpGaD
Bosutinib—SRC—Developmental Biology—IL6—systemic lupus erythematosus	3.46e-07	3.77e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.46e-07	3.77e-06	CbGpPWpGaD
Bosutinib—ERBB3—Disease—IL6—systemic lupus erythematosus	3.46e-07	3.77e-06	CbGpPWpGaD
Bosutinib—LCK—Innate Immune System—IL6—systemic lupus erythematosus	3.45e-07	3.76e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—CD4—systemic lupus erythematosus	3.43e-07	3.74e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL2—systemic lupus erythematosus	3.43e-07	3.74e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.43e-07	3.73e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL2—systemic lupus erythematosus	3.42e-07	3.72e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.41e-07	3.72e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IFNG—systemic lupus erythematosus	3.41e-07	3.71e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—F2—systemic lupus erythematosus	3.41e-07	3.71e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—PTGS2—systemic lupus erythematosus	3.41e-07	3.71e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—EP300—systemic lupus erythematosus	3.4e-07	3.71e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TYK2—systemic lupus erythematosus	3.39e-07	3.7e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCR5—systemic lupus erythematosus	3.39e-07	3.69e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—EP300—systemic lupus erythematosus	3.39e-07	3.69e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—TYK2—systemic lupus erythematosus	3.36e-07	3.66e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—CDKN1B—systemic lupus erythematosus	3.35e-07	3.65e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—CDKN1A—systemic lupus erythematosus	3.35e-07	3.65e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL2RA—systemic lupus erythematosus	3.34e-07	3.64e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.34e-07	3.63e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.34e-07	3.63e-06	CbGpPWpGaD
Bosutinib—PTK2—Immune System—IL6—systemic lupus erythematosus	3.34e-07	3.63e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—NOS3—systemic lupus erythematosus	3.33e-07	3.63e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TYK2—systemic lupus erythematosus	3.31e-07	3.61e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—C3—systemic lupus erythematosus	3.31e-07	3.61e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NAT2—systemic lupus erythematosus	3.31e-07	3.6e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.3e-07	3.6e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—NOS3—systemic lupus erythematosus	3.3e-07	3.59e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—EP300—systemic lupus erythematosus	3.29e-07	3.59e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—CD4—systemic lupus erythematosus	3.29e-07	3.58e-06	CbGpPWpGaD
Bosutinib—YES1—Immune System—IL6—systemic lupus erythematosus	3.29e-07	3.58e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—F2—systemic lupus erythematosus	3.28e-07	3.58e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CD80—systemic lupus erythematosus	3.27e-07	3.56e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—NOS3—systemic lupus erythematosus	3.25e-07	3.54e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.25e-07	3.54e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—EP300—systemic lupus erythematosus	3.25e-07	3.54e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TYK2—systemic lupus erythematosus	3.24e-07	3.53e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.24e-07	3.52e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL2—systemic lupus erythematosus	3.23e-07	3.52e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—CDKN1B—systemic lupus erythematosus	3.23e-07	3.51e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—CDKN1A—systemic lupus erythematosus	3.23e-07	3.51e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.22e-07	3.5e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TYK2—systemic lupus erythematosus	3.19e-07	3.48e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—EP300—systemic lupus erythematosus	3.19e-07	3.47e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—NOS3—systemic lupus erythematosus	3.18e-07	3.47e-06	CbGpPWpGaD
Bosutinib—CSNK1E—Signaling Pathways—IL6—systemic lupus erythematosus	3.18e-07	3.46e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TYK2—systemic lupus erythematosus	3.18e-07	3.46e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CD80—systemic lupus erythematosus	3.15e-07	3.43e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—TGFB1—systemic lupus erythematosus	3.15e-07	3.43e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—NOS3—systemic lupus erythematosus	3.13e-07	3.41e-06	CbGpPWpGaD
Bosutinib—IRAK1—Immune System—IL6—systemic lupus erythematosus	3.12e-07	3.4e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.12e-07	3.4e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—NOS3—systemic lupus erythematosus	3.12e-07	3.39e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—CDKN1B—systemic lupus erythematosus	3.1e-07	3.37e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—CDKN1A—systemic lupus erythematosus	3.09e-07	3.37e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—EP300—systemic lupus erythematosus	3.08e-07	3.35e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.08e-07	3.35e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—TGFB1—systemic lupus erythematosus	3.07e-07	3.34e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—EP300—systemic lupus erythematosus	3.07e-07	3.34e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—MMP9—systemic lupus erythematosus	3.06e-07	3.33e-06	CbGpPWpGaD
Bosutinib—SRC—Innate Immune System—IL6—systemic lupus erythematosus	3.06e-07	3.33e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.05e-07	3.32e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—CD4—systemic lupus erythematosus	3.04e-07	3.31e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CCL2—systemic lupus erythematosus	3.04e-07	3.31e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL2—systemic lupus erythematosus	3.03e-07	3.3e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—PTGS2—systemic lupus erythematosus	3.02e-07	3.28e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—RXRA—systemic lupus erythematosus	3.01e-07	3.28e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—CDKN1A—systemic lupus erythematosus	2.98e-07	3.24e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—TGFB1—systemic lupus erythematosus	2.96e-07	3.22e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—TGFB1—systemic lupus erythematosus	2.94e-07	3.2e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—EP300—systemic lupus erythematosus	2.94e-07	3.2e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Immune System—IL6—systemic lupus erythematosus	2.94e-07	3.2e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CCL2—systemic lupus erythematosus	2.93e-07	3.19e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.92e-07	3.18e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—F2—systemic lupus erythematosus	2.91e-07	3.17e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—EP300—systemic lupus erythematosus	2.9e-07	3.16e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.89e-07	3.14e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.86e-07	3.12e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—CDKN1B—systemic lupus erythematosus	2.86e-07	3.11e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—CDKN1A—systemic lupus erythematosus	2.86e-07	3.11e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—EP300—systemic lupus erythematosus	2.83e-07	3.09e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL2—systemic lupus erythematosus	2.82e-07	3.08e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.82e-07	3.07e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.82e-07	3.07e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling by GPCR—IL6—systemic lupus erythematosus	2.81e-07	3.06e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CD80—systemic lupus erythematosus	2.79e-07	3.04e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TYK2—systemic lupus erythematosus	2.76e-07	3e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.76e-07	3e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL2—systemic lupus erythematosus	2.76e-07	3e-06	CbGpPWpGaD
Bosutinib—ERBB4—Signaling Pathways—IL6—systemic lupus erythematosus	2.75e-07	2.99e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.75e-07	2.99e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—EP300—systemic lupus erythematosus	2.72e-07	2.96e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.72e-07	2.96e-06	CbGpPWpGaD
Bosutinib—PTK2B—Signaling Pathways—IL6—systemic lupus erythematosus	2.71e-07	2.95e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—NOS3—systemic lupus erythematosus	2.71e-07	2.95e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.7e-07	2.94e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL2—systemic lupus erythematosus	2.7e-07	2.94e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.68e-07	2.92e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—MMP9—systemic lupus erythematosus	2.67e-07	2.91e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.66e-07	2.9e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TYK2—systemic lupus erythematosus	2.66e-07	2.89e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL2—systemic lupus erythematosus	2.66e-07	2.89e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL2—systemic lupus erythematosus	2.64e-07	2.88e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—CDKN1A—systemic lupus erythematosus	2.64e-07	2.87e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling by GPCR—IL6—systemic lupus erythematosus	2.63e-07	2.86e-06	CbGpPWpGaD
Bosutinib—ROCK1—Signaling Pathways—IL6—systemic lupus erythematosus	2.61e-07	2.84e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—NOS3—systemic lupus erythematosus	2.61e-07	2.84e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—MMP9—systemic lupus erythematosus	2.61e-07	2.84e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.6e-07	2.83e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CCL2—systemic lupus erythematosus	2.59e-07	2.82e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Immune System—IL6—systemic lupus erythematosus	2.57e-07	2.8e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—TGFB1—systemic lupus erythematosus	2.56e-07	2.78e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—MMP9—systemic lupus erythematosus	2.55e-07	2.78e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.55e-07	2.77e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—EP300—systemic lupus erythematosus	2.53e-07	2.76e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.52e-07	2.74e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—MMP9—systemic lupus erythematosus	2.51e-07	2.74e-06	CbGpPWpGaD
Bosutinib—RPS6KB1—Signaling Pathways—IL6—systemic lupus erythematosus	2.51e-07	2.74e-06	CbGpPWpGaD
Bosutinib—MAP2K5—Signaling Pathways—IL6—systemic lupus erythematosus	2.51e-07	2.74e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—EP300—systemic lupus erythematosus	2.51e-07	2.73e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Immune System—IL6—systemic lupus erythematosus	2.51e-07	2.73e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.51e-07	2.73e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—MMP9—systemic lupus erythematosus	2.5e-07	2.72e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.49e-07	2.71e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—EP300—systemic lupus erythematosus	2.47e-07	2.69e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—TGFB1—systemic lupus erythematosus	2.46e-07	2.68e-06	CbGpPWpGaD
Bosutinib—LYN—Immune System—IL6—systemic lupus erythematosus	2.45e-07	2.67e-06	CbGpPWpGaD
Bosutinib—ABL1—Immune System—IL6—systemic lupus erythematosus	2.44e-07	2.66e-06	CbGpPWpGaD
Bosutinib—ERBB3—Signaling Pathways—IL6—systemic lupus erythematosus	2.42e-07	2.64e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—EP300—systemic lupus erythematosus	2.42e-07	2.64e-06	CbGpPWpGaD
Bosutinib—FYN—Immune System—IL6—systemic lupus erythematosus	2.42e-07	2.63e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Immune System—IL6—systemic lupus erythematosus	2.4e-07	2.62e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.4e-07	2.61e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—EP300—systemic lupus erythematosus	2.38e-07	2.6e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—EP300—systemic lupus erythematosus	2.37e-07	2.58e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Disease—IL6—systemic lupus erythematosus	2.37e-07	2.58e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TYK2—systemic lupus erythematosus	2.35e-07	2.56e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.35e-07	2.55e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.34e-07	2.55e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Disease—IL6—systemic lupus erythematosus	2.31e-07	2.52e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—NOS3—systemic lupus erythematosus	2.31e-07	2.51e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL2—systemic lupus erythematosus	2.3e-07	2.5e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.29e-07	2.5e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling by GPCR—IL6—systemic lupus erythematosus	2.28e-07	2.49e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2.26e-07	2.46e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.26e-07	2.46e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—VEGFA—systemic lupus erythematosus	2.25e-07	2.45e-06	CbGpPWpGaD
Bosutinib—FYN—Disease—IL6—systemic lupus erythematosus	2.23e-07	2.43e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Disease—IL6—systemic lupus erythematosus	2.22e-07	2.41e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL2—systemic lupus erythematosus	2.21e-07	2.41e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.2e-07	2.4e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—TGFB1—systemic lupus erythematosus	2.18e-07	2.37e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—MMP9—systemic lupus erythematosus	2.17e-07	2.37e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.16e-07	2.36e-06	CbGpPWpGaD
Bosutinib—PTK2—Signaling Pathways—IL6—systemic lupus erythematosus	2.16e-07	2.35e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.15e-07	2.34e-06	CbGpPWpGaD
Bosutinib—YES1—Signaling Pathways—IL6—systemic lupus erythematosus	2.13e-07	2.32e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.11e-07	2.29e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—MMP9—systemic lupus erythematosus	2.09e-07	2.28e-06	CbGpPWpGaD
Bosutinib—EGFR—Immune System—IL6—systemic lupus erythematosus	2.09e-07	2.27e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—CDKN1A—systemic lupus erythematosus	2.09e-07	2.27e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.07e-07	2.26e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.06e-07	2.24e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—EP300—systemic lupus erythematosus	2.06e-07	2.24e-06	CbGpPWpGaD
Bosutinib—IRAK1—Signaling Pathways—IL6—systemic lupus erythematosus	2.02e-07	2.2e-06	CbGpPWpGaD
Bosutinib—LCK—Immune System—IL6—systemic lupus erythematosus	2.01e-07	2.19e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CDKN1B—systemic lupus erythematosus	2e-07	2.18e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—EP300—systemic lupus erythematosus	1.99e-07	2.16e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL2—systemic lupus erythematosus	1.96e-07	2.13e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.95e-07	2.12e-06	CbGpPWpGaD
Bosutinib—EGFR—Disease—IL6—systemic lupus erythematosus	1.93e-07	2.1e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	1.9e-07	2.07e-06	CbGpPWpGaD
Bosutinib—MAP3K7—Signaling Pathways—IL6—systemic lupus erythematosus	1.9e-07	2.07e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.88e-07	2.05e-06	CbGpPWpGaD
Bosutinib—LCK—Disease—IL6—systemic lupus erythematosus	1.86e-07	2.02e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	1.85e-07	2.02e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—MMP9—systemic lupus erythematosus	1.85e-07	2.02e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—CDKN1A—systemic lupus erythematosus	1.85e-07	2.01e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.79e-07	1.95e-06	CbGpPWpGaD
Bosutinib—SRC—Immune System—IL6—systemic lupus erythematosus	1.78e-07	1.94e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—EP300—systemic lupus erythematosus	1.76e-07	1.91e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.73e-07	1.88e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—ALB—systemic lupus erythematosus	1.71e-07	1.86e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—VEGFA—systemic lupus erythematosus	1.66e-07	1.81e-06	CbGpPWpGaD
Bosutinib—MAP2K2—Signaling Pathways—IL6—systemic lupus erythematosus	1.66e-07	1.81e-06	CbGpPWpGaD
Bosutinib—SRC—Disease—IL6—systemic lupus erythematosus	1.64e-07	1.79e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	1.63e-07	1.78e-06	CbGpPWpGaD
Bosutinib—PDGFRB—Signaling Pathways—IL6—systemic lupus erythematosus	1.62e-07	1.76e-06	CbGpPWpGaD
Bosutinib—LYN—Signaling Pathways—IL6—systemic lupus erythematosus	1.59e-07	1.73e-06	CbGpPWpGaD
Bosutinib—FYN—Signaling Pathways—IL6—systemic lupus erythematosus	1.56e-07	1.7e-06	CbGpPWpGaD
Bosutinib—MAP2K1—Signaling Pathways—IL6—systemic lupus erythematosus	1.55e-07	1.69e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—TGFB1—systemic lupus erythematosus	1.53e-07	1.66e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	1.49e-07	1.63e-06	CbGpPWpGaD
Bosutinib—EGFR—Signaling Pathways—IL6—systemic lupus erythematosus	1.35e-07	1.47e-06	CbGpPWpGaD
Bosutinib—LCK—Signaling Pathways—IL6—systemic lupus erythematosus	1.3e-07	1.42e-06	CbGpPWpGaD
Bosutinib—ABCB1—Metabolism—EP300—systemic lupus erythematosus	1.24e-07	1.35e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	1.17e-07	1.27e-06	CbGpPWpGaD
Bosutinib—SRC—Signaling Pathways—IL6—systemic lupus erythematosus	1.15e-07	1.25e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	1.05e-07	1.15e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	1.01e-07	1.1e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	9.21e-08	1e-06	CbGpPWpGaD
Bosutinib—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	7.66e-08	8.34e-07	CbGpPWpGaD
